Search by Drug Name or NDC
NDC 63323-0651-04 Adenosine 3 mg/mL Details
Adenosine 3 mg/mL
Adenosine is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is ADENOSINE.
Product Information
NDC | 63323-0651 |
---|---|
Product ID | 63323-651_82a5c8e7-05d6-4f65-8677-af4426952dd7 |
Associated GPIs | 35500010002015 35500010002020 94200005002010 |
GCN Sequence Number | 013630 |
GCN Sequence Number Description | adenosine VIAL 3 MG/ML INTRAVEN |
HIC3 | A2A |
HIC3 Description | ANTIARRHYTHMICS |
GCN | 35350 |
HICL Sequence Number | 003734 |
HICL Sequence Number Description | ADENOSINE |
Brand/Generic | Generic |
Proprietary Name | Adenosine |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | ADENOSINE |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 3 |
Active Ingredient Units | mg/mL |
Substance Name | ADENOSINE |
Labeler Name | Fresenius Kabi USA, LLC |
Pharmaceutical Class | Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA077133 |
Listing Certified Through | 2024-12-31 |
Package
NDC 63323-0651-04 (63323065104)
NDC Package Code | 63323-651-04 |
---|---|
Billing NDC | 63323065104 |
Package | 10 VIAL, SINGLE-USE in 1 TRAY (63323-651-04) / 4 mL in 1 VIAL, SINGLE-USE (63323-651-01) |
Marketing Start Date | 2005-11-23 |
NDC Exclude Flag | N |
Pricing Information | N/A |